GlassScriptPhysician profile
Vahan Cepkinian
NPI 1134214091
$1,290.90
in general payments reported to CMS, 2019-2025
9 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $66.22 · 2021: $590 · 2022: $412 · 2024: $88.21 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $487.54 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $451.36 | 2021-2022 | |
| Amgen INC. | $122.17 | 2025 | |
| Heraeus Medical, LLC. | $61.79 | 2024-2025 | |
| Anika Therapeutics, INC. | $47.59 | 2021 | |
| Medical Device Business Services, INC. | $35.20 | 2021-2022 | |
| Depuy Synthes Sales INC. | $34.74 | 2021-2024 | Monovisc |
| Merck Sharp & Dohme LLC | $33.95 | 2022-2024 | Bridion |
| Avanos Medical | $16.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vahan Cepkinian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.